8-K Announcements
6Mar 11, 2026·SEC
Feb 2, 2026·SEC
Feb 2, 2026·SEC
Petco Health and Wellness Company, Inc. (WOOF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when WOOF posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Petco Health and Wellness Company, Inc. (WOOF) stock price & volume — 10-year historical chart
Petco Health and Wellness Company, Inc. (WOOF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Petco Health and Wellness Company, Inc. (WOOF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 3, 2026 | $0.01vs $0.02+150.0% | $1.5Bvs $1.5B+0.7% |
| Q2 2026 | Mar 11, 2026 | $0.01vs $0.02-50.0% | $1.5Bvs $1.5B+0.2% |
| Q4 2025 | Nov 25, 2025 | $0.05vs $0.02+204.5% | $1.5Bvs $1.5B-0.3% |
| Q3 2025 | Aug 28, 2025 | $0.08vs $0.01+700.0% | $1.5Bvs $1.5B+1.3% |
Petco Health and Wellness Company, Inc. (WOOF) competitors in Pet Products and Services Retail — business model, growth, and fundamentals comparison
Petco Health and Wellness Company, Inc. (WOOF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Petco Health and Wellness Company, Inc. (WOOF) annual income statement — 10-year revenue, gross profit & net income history
| Metric | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 4.39B | 4.43B | 4.92B | 5.81B | 6.04B | 6.26B | 6.12B | 5.96B | 5.97B |
Revenue Growth % | - | 0.96% | 10.95% | 18.03% | 3.94% | 3.63% | -2.22% | -2.53% | -1.2% |
Cost of Goods Sold | 2.49B | 2.53B | 2.81B | 3.38B | 3.61B | 3.9B | 3.79B | 3.66B | 3.66B |
COGS % of Revenue | 56.63% | 57.01% | 57.18% | 58.21% | 59.79% | 62.37% | 62% | 61.33% | - |
Gross Profit | 1.9B▲ 0% | 1.91B▲ 0.1% | 2.11B▲ 10.5% | 2.43B▲ 15.2% | 2.43B▲ 0.0% | 2.35B▼ 3.0% | 2.32B▼ 1.3% | 2.31B▼ 0.8% | 2.3B▲ 0% |
Gross Margin % | 43.37% | 42.99% | 42.82% | 41.79% | 40.21% | 37.63% | 38% | 38.67% | 38.48% |
Gross Profit Growth % | - | 0.09% | 10.5% | 15.18% | 0.02% | -3.02% | -1.25% | -0.83% | - |
Operating Expenses | 1.75B | 1.8B | 1.91B | 2.16B | 2.2B | 3.53B | 2.32B | 2.18B | 2.18B |
OpEx % of Revenue | 39.76% | 40.5% | 38.87% | 37.2% | 36.47% | 56.5% | 37.89% | 36.65% | - |
Selling, General & Admin | 1.73B | 1.78B | 1.91B | 2.16B | 2.2B | 2.31B | 2.32B | 2.18B | 2.18B |
SG&A % of Revenue | 39.32% | 40.07% | 38.87% | 37.2% | 36.47% | 36.95% | 37.89% | 36.65% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 373.17M | 19M | 0 | 0 | 0 | 1.22B | 0 | 0 | 0 |
Operating Income | -214.72M▲ 0% | 110.6M▲ 151.5% | 194.42M▲ 75.8% | 266.07M▲ 36.9% | 225.56M▼ 15.2% | -1.18B▼ 623.3% | 7.05M▲ 100.6% | 120.43M▲ 1608.0% | 110.3M▲ 0% |
Operating Margin % | -4.89% | 2.49% | 3.95% | 4.58% | 3.74% | -18.87% | 0.12% | 2.02% | 1.85% |
Operating Income Growth % | - | 151.51% | 75.79% | 36.85% | -15.23% | -623.28% | 100.6% | 1608.03% | - |
EBITDA | -27.72M | 284.14M | 369.26M | 438.5M | 419.39M | -979.53M | -1.46M | 317.14M | 305.77M |
EBITDA Margin % | -0.63% | 6.41% | 7.51% | 7.55% | 6.95% | -15.66% | -0.02% | 5.32% | 5.12% |
EBITDA Growth % | - | 1124.94% | 29.96% | 18.75% | -4.36% | -333.56% | 99.85% | 21777.58% | 4.3% |
D&A (Non-Cash Add-back) | 187M | 173.54M | 174.84M | 172.43M | 193.83M | 200.78M | -8.51M | 196.71M | 195.71M |
EBIT | -214.76M | 110.94M | 177.53M | 279.79M | 213.92M | -1.17B | 15.56M | 146.53M | 139.87M |
Net Interest Income | -243.32M | -252.68M | -218.43M | -77.33M | -100.61M | -147.5M | -139.82M | -124.89M | -122.95M |
Interest Income | 420K | 335K | 653K | 62K | 1.03M | 3.4M | 3.71M | 6.3M | 6.44M |
Interest Expense | 243.74M | 253.02M | 219.08M | 77.4M | 101.64M | 150.91M | 143.53M | 131.2M | 130.49M |
Other Income/Expense | -243.78M | -250.24M | -235.98M | -52.79M | -100.3M | -127.51M | -116.35M | -105.1M | -120.02M |
Pretax Income | -458.5M▲ 0% | -139.64M▲ 69.5% | -41.55M▲ 70.2% | 213.28M▲ 613.2% | 125.26M▼ 41.3% | -1.31B▼ 1144.1% | -109.3M▲ 91.6% | 15.33M▲ 114.0% | 8.68M▲ 0% |
Pretax Margin % | -10.44% | -3.15% | -0.84% | 3.67% | 2.08% | -20.91% | -1.79% | 0.26% | 0.15% |
Income Tax | -45.84M | -35.66M | -3.34M | 53.47M | 35.35M | -27.61M | -7.48M | 6.27M | 3.1M |
Effective Tax Rate % | 10% | 25.54% | 8.03% | 25.07% | 28.22% | 2.11% | 6.84% | 40.87% | 35.7% |
Net Income | -413.79M▲ 0% | -95.87M▲ 76.8% | -26.48M▲ 72.4% | 164.42M▲ 720.8% | 90.8M▼ 44.8% | -1.28B▼ 1509.9% | -101.82M▲ 92.0% | 9.07M▲ 108.9% | -23.54M▲ 0% |
Net Margin % | -9.42% | -2.16% | -0.54% | 2.83% | 1.5% | -20.47% | -1.66% | 0.15% | -0.39% |
Net Income Growth % | - | 76.83% | 72.38% | 720.84% | -44.77% | -1509.91% | 92.05% | 108.9% | 16.53% |
Net Income (Continuing) | -413.79M | -103.98M | -38.22M | 159.81M | 89.91M | -1.28B | -101.82M | 9.07M | 5.58M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | -8.33M | -13.58M | -18.2M | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.28▲ 0% | -0.07▲ 76.5% | -0.13▼ 97.9% | 0.62▲ 576.9% | 0.34▼ 45.2% | -4.78▼ 1505.9% | -0.37▲ 92.3% | 0.03▲ 108.6% | -0.08▲ 0% |
EPS Growth % | - | 76.54% | -97.87% | 576.92% | -45.16% | -1505.88% | 92.26% | 108.57% | 18.91% |
EPS (Basic) | -0.28 | -0.07 | -0.13 | 0.62 | 0.34 | -4.78 | -0.37 | 0.03 | - |
Diluted Shares Outstanding | 1.46B | 1.46B | 210.68M | 265.34M | 265.95M | 267.55M | 273.41M | 286.15M | 283.68M |
Basic Shares Outstanding | 1.46B | 1.44B | 203.72M | 265.19M | 265.52M | 267.55M | 273.41M | 279.56M | 283.68M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
Petco Health and Wellness Company, Inc. (WOOF) balance sheet — assets, liabilities & shareholders' equity
| Metric | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 761.61M | 711M | 777.55M | 1.07B | 1.02B | 951.74M | 973.62M | 1.02B | 960.84M |
Cash & Short-Term Investments | 180.65M | 148.78M | 111.4M | 211.6M | 201.9M | 125.43M | 165.76M | 256.74M | 166.8M |
Cash Only | 180.65M | 148.78M | 111.4M | 211.6M | 201.9M | 125.43M | 165.76M | 256.74M | 166.8M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 27.88M | 31.52M | 41.83M | 55.62M | 49.58M | 44.37M | 40.42M | 45.81M | 36.93M |
Days Sales Outstanding | 2.32 | 2.59 | 3.1 | 3.5 | 3 | 2.59 | 2.41 | 2.8 | 2.45 |
Inventory | 470.14M | 478.97M | 538.67M | 675.11M | 652.43M | 684.5M | 653.33M | 590.21M | 632.91M |
Days Inventory Outstanding | 68.99 | 69.15 | 69.88 | 72.89 | 65.99 | 64.04 | 62.89 | 58.92 | 61.15 |
Other Current Assets | 34.17M | 26.88M | 45.61M | 86.09M | 60.81M | 38.83M | 60.59M | 127.03M | 60.16M |
Total Non-Current Assets | 4.16B | 5.45B | 5.3B | 5.43B | 5.6B | 4.41B | 4.22B | 4.15B | 4.12B |
Property, Plant & Equipment | 683.55M | 2.12B | 1.96B | 2.07B | 2.2B | 2.2B | 2.03B | 1.94B | 1.91B |
Fixed Asset Turnover | 6.43x | 2.10x | 2.52x | 2.81x | 2.74x | 2.84x | 3.02x | 3.07x | 2.51x |
Goodwill | 2.18B | 2.18B | 2.18B | 2.18B | 2.19B | 980.3M | 980.06M | 980.06M | 980.06M |
Intangible Assets | 1.17B | 1.03B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 13.95M | 0 | 0 |
Other Non-Current Assets | 130.93M | 122.39M | 138.19M | 152.79M | 176.81M | 205.69M | 174.02M | 203.83M | 207.47M |
Total Assets | 4.92B▲ 0% | 6.16B▲ 25.0% | 6.08B▼ 1.3% | 6.5B▲ 6.9% | 6.61B▲ 1.8% | 5.36B▼ 18.9% | 5.19B▼ 3.1% | 5.17B▼ 0.4% | 5.08B▲ 0% |
Asset Turnover | 0.89x | 0.72x | 0.81x | 0.89x | 0.91x | 1.17x | 1.18x | 1.15x | 1.16x |
Asset Growth % | - | 24.99% | -1.29% | 6.95% | 1.77% | -18.9% | -3.15% | -0.4% | -3.58% |
Total Current Liabilities | 543.47M | 841.94M | 875.31M | 1.05B | 1.02B | 1.11B | 1.14B | 1.13B | 1.13B |
Accounts Payable | 276.93M | 293.2M | 339.49M | 403.98M | 381.21M | 485.13M | 492.88M | 450.55M | 480.66M |
Days Payables Outstanding | 40.64 | 42.33 | 44.04 | 43.62 | 38.56 | 45.39 | 47.44 | 44.98 | 44.55 |
Short-Term Debt | 28.35M | 28.64M | 2.2M | 21.76M | 22.79M | 15.96M | 23.31M | 324.69M | 325.64M |
Deferred Revenue (Current) | 0 | 0 | 15.53M | 18M | 23.05M | 33.52M | 29.56M | 0 | 0 |
Other Current Liabilities | 94.27M | 93.69M | 129.48M | 150.63M | 89.93M | 85.3M | 134.15M | 358.9M | 216.18M |
Current Ratio | 1.40x | 0.84x | 0.89x | 1.02x | 0.99x | 0.86x | 0.85x | 0.90x | 0.85x |
Quick Ratio | 0.54x | 0.28x | 0.27x | 0.38x | 0.36x | 0.24x | 0.28x | 0.38x | 0.29x |
Cash Conversion Cycle | 30.67 | 29.42 | 28.94 | 32.77 | 30.43 | 21.24 | 17.86 | 16.75 | 19.05 |
Total Non-Current Liabilities | 3.74B | 4.75B | 3.15B | 3.19B | 3.21B | 3.07B | 2.94B | 2.88B | 2.8B |
Long-Term Debt | 3.2B | 3.23B | 1.65B | 1.64B | 1.63B | 1.58B | 1.58B | 1.49B | 1.46B |
Capital Lease Obligations | 0 | 1.16B | 1.1B | 1.12B | 1.17B | 1.12B | 1.05B | 1.05B | 4.13B |
Deferred Tax Liabilities | 304.2M | 265.28M | 280.92M | 318.36M | 303.12M | 251.63M | 217.71M | 234.91M | 911.75M |
Other Non-Current Liabilities | 241.38M | 101.65M | 122.92M | 109.05M | 106.84M | 112.9M | 100.18M | 104.41M | 104.56M |
Total Liabilities | 4.29B | 5.59B | 4.02B | 4.24B | 4.23B | 4.18B | 4.08B | 4.01B | 3.93B |
Total Debt | 3.23B | 4.69B | 3B | 3.05B | 3.13B | 3.04B | 2.96B | 2.86B | 2.78B |
Net Debt | 3.05B | 4.54B | 2.89B | 2.84B | 2.93B | 2.92B | 2.79B | 2.6B | 2.62B |
Debt / Equity | 5.06x | 8.36x | 1.46x | 1.35x | 1.32x | 2.57x | 2.66x | 2.46x | 2.41x |
Debt / EBITDA | - | 16.51x | 8.13x | 6.95x | 7.47x | - | - | 9.02x | 9.11x |
Net Debt / EBITDA | - | 15.99x | 7.83x | 6.47x | 6.99x | - | - | 8.21x | 8.56x |
Interest Coverage | -0.88x | 0.44x | 0.81x | 3.62x | 2.10x | -7.77x | 0.11x | 1.12x | 1.07x |
Total Equity | 637.91M▲ 0% | 561.06M▼ 12.0% | 2.06B▲ 266.3% | 2.26B▲ 9.8% | 2.38B▲ 5.6% | 1.18B▼ 50.3% | 1.11B▼ 6.0% | 1.16B▲ 4.5% | 1.16B▲ 0% |
Equity Growth % | - | -12.05% | 266.32% | 9.76% | 5.57% | -50.26% | -5.98% | 4.55% | 12.65% |
Book Value per Share | 0.44 | 0.38 | 9.76 | 8.50 | 8.95 | 4.43 | 4.07 | 4.07 | 4.07 |
Total Shareholders' Equity | 637.91M | 569.39M | 2.07B | 2.27B | 2.38B | 1.18B | 1.11B | 1.16B | 1.16B |
Common Stock | 1.35B | 1.36B | 264K | 265K | 266K | 269K | 277K | 282K | 285K |
Retained Earnings | -707.52M | -780.47M | -22.25M | 142.17M | 232.97M | -1.05B | -1.15B | -1.14B | -1.16B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -2.19M | -8.27M | -1.27M | -2.24M | -4.1M | 1.82M | -18.08M | -8.39M | -8.72M |
Minority Interest | 0 | -8.33M | -13.58M | -18.2M | 0 | 0 | 0 | 0 | 0 |
Petco Health and Wellness Company, Inc. (WOOF) cash flow — operating, investing & free cash flow history
| Metric | Feb'19 | Feb'20 | Jan'21 | Jan'22 | Jan'23 | Feb'24 | Feb'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 203.2M | 110.34M | 268.62M | 358.21M | 346M | 215.72M | 177.67M | 314.05M | 360.18M |
Operating CF Margin % | 4.63% | 2.49% | 5.46% | 6.17% | 5.73% | 3.45% | 2.9% | 5.27% | - |
Operating CF Growth % | - | -45.7% | 143.45% | 33.36% | -3.41% | -37.65% | -17.64% | 76.76% | 227.87% |
Net Income | -413.79M | -103.98M | -31.74M | 159.81M | 89.91M | -1.28B | -101.82M | 9.07M | -23.54M |
Depreciation & Amortization | 187M | 173.54M | 174.84M | 172.43M | 193.83M | 200.78M | 199.73M | 196.71M | 246.2M |
Stock-Based Compensation | 8.45M | 9.49M | 12.91M | 49.27M | 60.78M | 81.86M | 50.21M | 32.65M | 30.39M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.05M | 25.44M |
Other Non-Cash Items | 364.91M | 452.47M | 517.21M | 452.38M | 428.69M | 1.59B | 370.98M | 396.49M | 414.14M |
Working Capital Changes | 56.63M | -421.18M | -404.61M | -475.66M | -427.21M | -372.06M | -341.43M | -337.91M | -370.9M |
Change in Receivables | 23.63M | -3.85M | -10.31M | -13.79M | 6.04M | 5.21M | 4.18M | -5.62M | -966K |
Change in Inventory | 644K | -8.19M | -60.63M | -136.4M | 22.68M | -32.07M | 30.77M | 63.12M | 12.56M |
Change in Payables | 23.77M | 15.93M | 46.3M | 71.78M | -22.76M | 103.92M | 8.48M | -42.99M | 6.61M |
Cash from Investing | -142.68M | -139.04M | -157.19M | -237.08M | -320.32M | -207.44M | -123.9M | -124.56M | -164.6M |
Capital Expenditures | -148.06M | -156.91M | -159.56M | -239.11M | -278.02M | -225.6M | -127.99M | -127.1M | -128.11M |
CapEx % of Revenue | 3.37% | 3.54% | 3.24% | 4.12% | 4.61% | 3.61% | 2.09% | 2.13% | 2.14% |
Acquisitions | 0 | -1.61M | 0 | -4.33M | -44.64M | -6.72M | -629K | 2.54M | 1.26M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 6.15M | 20.06M | 3.3M | 226K | 2.34M | 0 | 4.17M | 0 | -37.75M |
Cash from Financing | -32.1M | -3.07M | -146.61M | -18.78M | -33.84M | -85.35M | -8.75M | -101.75M | -106.68M |
Debt Issued (Net) | -28.14M | 303K | -1.08B | 5.58M | -22.08M | -80.92M | -5.71M | -95.25M | -89.67M |
Equity Issued (Net) | -111K | 0 | 935.94M | 0 | 0 | 0 | 2.5M | 3.68M | 3.72M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -111K | 0 | -105K | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -3.85M | -3.37M | -250K | -24.36M | -11.76M | -4.43M | -5.55M | -10.17M | -20.72M |
Net Change in Cash | 28.42M▲ 0% | -31.77M▼ 211.8% | -35.18M▼ 10.7% | 102.35M▲ 390.9% | -8.16M▼ 108.0% | -77.08M▼ 844.2% | 45.02M▲ 158.4% | 87.75M▲ 94.9% | 75.74M▲ 0% |
Free Cash Flow | 54.84M▲ 0% | -47.02M▼ 185.7% | 109.06M▲ 331.9% | 119.11M▲ 9.2% | 67.98M▼ 42.9% | -9.88M▼ 114.5% | 49.68M▲ 602.9% | 186.95M▲ 276.3% | 80.72M▲ 0% |
FCF Margin % | 1.25% | -1.06% | 2.22% | 2.05% | 1.13% | -0.16% | 0.81% | 3.14% | 1.35% |
FCF Growth % | - | -185.74% | 331.94% | 9.22% | -42.92% | -114.53% | 602.92% | 276.29% | 37.56% |
FCF per Share | 0.04 | -0.03 | 0.52 | 0.45 | 0.26 | -0.04 | 0.18 | 0.65 | 0.28 |
FCF Conversion (FCF/Net Income) | -0.49x | -1.15x | -10.14x | 2.18x | 3.81x | -0.17x | -1.75x | 34.64x | -3.43x |
Interest Paid | 213.25M | 217.66M | 178.96M | 64.55M | 89.28M | 142.11M | 138.62M | 0 | 62.98M |
Taxes Paid | 11.38M | 15.04M | 2.39M | 16.09M | 14.44M | 32.19M | 34.84M | 0 | 3.29M |
Petco Health and Wellness Company, Inc. (WOOF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -15.99% | -2.02% | 7.63% | 3.92% | -71.8% | -8.86% | 0.8% | -2.03% |
Return on Invested Capital (ROIC) | 1.89% | 2.9% | 3.98% | 3.25% | -18.81% | 0.13% | 2.35% | 2.02% |
Gross Margin | 42.99% | 42.82% | 41.79% | 40.21% | 37.63% | 38% | 38.67% | 38.48% |
Net Margin | -2.16% | -0.54% | 2.83% | 1.5% | -20.47% | -1.66% | 0.15% | -0.39% |
Debt / Equity | 8.36x | 1.46x | 1.35x | 1.32x | 2.57x | 2.66x | 2.46x | 2.41x |
Interest Coverage | 0.44x | 0.81x | 3.62x | 2.10x | -7.77x | 0.11x | 1.12x | 1.07x |
FCF Conversion | -1.15x | -10.14x | 2.18x | 3.81x | -0.17x | -1.75x | 34.64x | -3.43x |
Revenue Growth | 0.96% | 10.95% | 18.03% | 3.94% | 3.63% | -2.22% | -2.53% | -1.2% |
Petco Health and Wellness Company, Inc. (WOOF) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 11, 2026·SEC
Feb 2, 2026·SEC
Feb 2, 2026·SEC
Petco Health and Wellness Company, Inc. (WOOF) stock FAQ — growth, dividends, profitability & financials explained
Petco Health and Wellness Company, Inc. (WOOF) reported $5.97B in revenue for fiscal year 2025. This represents a 36% increase from $4.39B in 2018.
Petco Health and Wellness Company, Inc. (WOOF) saw revenue decline by 2.5% over the past year.
Petco Health and Wellness Company, Inc. (WOOF) reported a net loss of $23.5M for fiscal year 2025.
Petco Health and Wellness Company, Inc. (WOOF) has a return on equity (ROE) of 0.8%. This is below average, suggesting room for improvement.
Petco Health and Wellness Company, Inc. (WOOF) generated $80.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.